InsidersTradesSigma
Follow the 쓰리빌리언 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has recorded 33 public disclosures. Market capitalisation: €166.1bn. The latest transaction was filed on 26 May 2026 (Purchase). Among the most active insiders: 한국산업은행. All data is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
6 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,852 of 29,063 companies
31.7
score / 100
Value25
Quality38
FCF yld-3.6%
Earn yld-3.4%
EV/EBITDA·
ROE-29%
Gross mgn100%
Net mgn-46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2026
Declarations33 total
1,509,827 sharesKRXDART:20260109000362
25 of 33 declarations
Acerca de 쓰리빌리언
쓰리빌리언 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud del paciente.